|
1
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Krex D, Klink B, Hartmann C, von Deimling
A, Pietsch T, Simon M, Sabel M, Steinbach JP, Heese O, Reifenberger
G, Weller M and Schackert G: Long-term survival with glioblastoma
multiforme. Brain. 130:2596–2606. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Andersson U, Guo D, Malmer B, Bergenheim
AT, Brannstrom T, Hedman H and Henriksson R: Epidermal growth
factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas.
Acta Neuropathol. 108:135–142. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bredel M, Pollack IF, Hamilton RL and
James CD: Epidermal growth factor receptor expression and gene
amplification in high-grade non-brainstem gliomas of childhood.
Clin Cancer Res. 5:1786–1792. 1999.PubMed/NCBI
|
|
5
|
McLendon RE, Turner K, Perkinson K and
Rich J: Second messenger systems in human gliomas. Arch Pathol Lab
Med. 131:1585–1590. 2007.PubMed/NCBI
|
|
6
|
Potti A, Forseen SE, Koka VK, Pervez H,
Koch M, Fraiman G, Mehdi SA and Levitt R: Determination of
HER-2/neu overexpression and clinical predictors of survival in a
cohort of 347 patients with primary malignant brain tumors. Cancer
Invest. 22:537–544. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schlegel J, Stumm G, Brandle K, Merdes A,
Mechtersheimer G, Hynes NE and Kiessling M: Amplification and
differential expression of members of the erbB-gene family in human
glioblastoma. J Neurooncol. 22:201–207. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tabori U, Rienstein S, Dromi Y,
Leider-Trejo L, Constantini S, Burstein Y, Dvir R, Amariglio N,
Toren A, Rechavi G, Izraeli S and Aviram A: Epidermal growth factor
receptor gene amplification and expression in disseminated
pediatric low-grade gliomas. J Neurosurg. 103:357–361.
2005.PubMed/NCBI
|
|
9
|
Gil-Benso R, Lopez-Gines C, Benito R,
Lopez-Guerrero JA, Callaghan RC, Pellin A, Roldan P and
Cerda-Nicolas M: Concurrent EGFR amplification and TP-53 mutation
in glioblastomas. Clin Neuropathol. 26:224–231. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nakamura JL: The epidermal growth factor
receptor in malignant gliomas: pathogenesis and therapeutic
implications. Expert Opin Ther Targets. 11:463–472. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Okada Y, Ohno C, Ueki K, Ogino M, Kawamoto
S and Kim P: Comparison of numerical change of epidermal growth
factor receptor gene among pre- and postradiation glioma, and
gliosis, and its clinical use. Brain Tumor Pathol. 24:15–18. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schober R, Bilzer T, Waha A, et al: The
epidermal growth factor receptor in glioblastoma: genomic
amplification, protein expression, and patient survival data in a
therapeutic trial. Clin Neuropathol. 14:169–174. 1995.
|
|
13
|
Shinojima N, Tada K, Shiraishi S, Kamiryo
T, Kochi M, Nakamura H, Makino K, Saya H, Hirano H, Kuratsu J, Oka
K, Ishimaru Y and Ushio Y: Prognostic value of epidermal growth
factor receptor in patients with glioblastoma multiforme. Cancer
Res. 63:6962–6970. 2003.PubMed/NCBI
|
|
14
|
Torp SH, Helseth E, Dalen A and Unsgaard
G: Epidermal growth factor receptor expression in human gliomas.
Cancer Immunol Immunother. 33:61–64. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Torp SH, Helseth E, Ryan L, Stolan S,
Dalen A and Unsgaard G: Amplification of the epidermal growth
factor receptor gene in human gliomas. Anticancer Res.
11:2095–2098. 1991.PubMed/NCBI
|
|
16
|
Gan HK, Kaye AH and Luwor RB: The EGFRvIII
variant in glioblastoma multiforme. J Clin Neurosci. 16:748–754.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lal A, Glazer CA, Martinson HM, Friedman
HS, Archer GE, Sampson JH and Riggins GJ: Mutant epidermal growth
factor receptor up-regulates molecular effectors of tumor invasion.
Cancer Res. 62:3335–3339. 2002.PubMed/NCBI
|
|
18
|
Sampson JH, Heimberger AB, Archer GE,
Aldape KD, Friedman AH, Friedman HS, Gilbert MR, Herndon JE II,
McLendon RE, Mitchell DA, Reardon DA, Sawaya R, Schmittling RJ, Shi
W, Vredenburgh JJ and Bigner DD: Immunologic escape after prolonged
progression-free survival with epidermal growth factor receptor
variant III peptide vaccination in patients with newly diagnosed
glioblastoma. J Clin Oncol. 28:4722–4729. 2010. View Article : Google Scholar
|
|
19
|
Maihle NJ, Baron AT, Barrette BA, Boardman
CH, Christensen TA, Cora EM, Faupel-Badger JM, Greenwood T, Juneja
SC, Lafky JM, Lee H, Reiter JL and Podratz KC: EGF/ErbB receptor
family in ovarian cancer. Cancer Treat Res. 107:247–258.
2002.PubMed/NCBI
|
|
20
|
Reiter JL and Maihle NJ: Characterization
and expression of novel 60-kDa and 110-kDa EGFR isoforms in human
placenta. Ann NY Acad Sci. 995:39–47. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Reiter JL, Threadgill DW, Eley GD, Strunk
KE, Danielsen AJ, Sinclair CS, Pearsall RS, Green PJ, Yee D,
Lampland AL, Balasubramaniam S, Crossley TD, Magnuson TR, James CD
and Maihle NJ: Comparative genomic sequence analysis and isolation
of human and mouse alternative EGFR transcripts encoding truncated
receptor isoforms. Genomics. 71:1–20. 2001. View Article : Google Scholar
|
|
22
|
Flickinger TW, Maihle NJ and Kung HJ: An
alternatively processed mRNA from the avian c-erbB gene encodes a
soluble, truncated form of the receptor that can block
ligand-dependent transformation. Mol Cell Biol. 12:883–893.
1992.PubMed/NCBI
|
|
23
|
Weber W, Gill GN and Spiess J: Production
of an epidermal growth factor receptor-related protein. Science.
224:294–297. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cadena DL and Gill GN: Expression and
purification of the epidermal growth factor receptor extracellular
domain utilizing a polycistronic expression system. Protein Expr
Purif. 4:177–186. 1993. View Article : Google Scholar
|
|
25
|
Greenfield C, Hiles I, Waterfield MD,
Federwisch M, Wollmer A, Blundell TL and McDonald N: Epidermal
growth factor binding induces a conformational change in the
external domain of its receptor. EMBO J. 8:4115–4123.
1989.PubMed/NCBI
|
|
26
|
Basu A, Raghunath M, Bishayee S and Das M:
Inhibition of tyrosine kinase activity of the epidermal growth
factor (EGF) receptor by a truncated receptor form that binds to
EGF: role for interreceptor interaction in kinase regulation. Mol
Cell Biol. 9:671–677. 1989.PubMed/NCBI
|
|
27
|
Hirsch FR, Varella-Garcia M, Bunn PA Jr,
Di Maria MV, Veve R, Bremmes RM, Baron AE, Zeng C and Franklin WA:
Epidermal growth factor receptor in non-small-cell lung carcinomas:
correlation between gene copy number and protein expression and
impact on prognosis. J Clin Oncol. 21:3798–3807. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Guillaudeau A, Durand K, Pommepuy I,
Robert S, Chaunavel A, Lacorre S, De Armas R, Bourtoumieux S, El
Demery M, Moreau JJ and Labrousse F: Determination of EGFR status
in gliomas: usefulness of immunohistochemistry and fluorescent in
situ hybridization. Appl Immunohistochem Mol Morphol. 17:220–226.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pfaffl MW: A new mathematical model for
relative quantification in real-time RT-PCR. Nucleic Acids Res.
29:e452001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Korshunov A, Sycheva R and Golanov A:
Molecular stratification of diagnostically challenging high-grade
gliomas composed of small cells: the utility of fluorescence in
situ hybridization. Clin Cancer Res. 10:7820–7826. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Marks RA, Zhang S, Montironi R, McCarthy
RP, MacLennan GT, Lopez-Beltran A, Jiang Z, Zhou H, Zheng S,
Davidson DD, Baldridge LA and Cheng L: Epidermal growth factor
receptor (EGFR) expression in prostatic adenocarcinoma after
hormonal therapy: a fluorescence in situ hybridization and
immunohistochemical analysis. Prostate. 68:919–923. 2008.
View Article : Google Scholar
|
|
32
|
Durand K, Guillaudeau A, Pommepuy I,
Mesturoux L, Chaunavel A, Gadeaud E, Porcheron M, Moreau JJ and
Labrousse F: Alpha-internexin expression in gliomas: relationship
with histological type and 1p, 19q, 10p and 10q status. J Clin
Pathol. 64:793–801. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Durand KS, Guillaudeau A, Weinbreck N, De
Armas R, Robert S, Chaunavel A, Pommepuy I, Bourthoumieu S, Caire
F, Sturtz FG and Labrousse FJ: 1p19q LOH patterns and expression of
p53 and Olig2 in gliomas: relation with histological types and
prognosis. Mod Pathol. 23:619–628. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hirose T, Ishizawa K and Shimada S:
Utility of in situ demonstration of 1p loss and p53 overexpression
in pathologic diagnosis of oligodendroglial tumors. Neuropathology.
30:586–596. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ligon KL, Alberta JA, Kho AT, Weiss J,
Kwaan MR, Nutt CL, Louis DN, Stiles CD and Rowitch DH: The
oligodendroglial lineage marker OLIG2 is universally expressed in
diffuse gliomas. J Neuropathol Exp Neurol. 63:499–509.
2004.PubMed/NCBI
|
|
36
|
Okada M, Yano H, Hirose Y, Nakayama N, Ohe
N, Shinoda J and Iwama T: Olig2 is useful in the differential
diagnosis of oligodendrogliomas and extraventricular neurocytomas.
Brain Tumor Pathol. 28:157–161. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Coulibaly B, Nanni I, Quilichini B,
Gaudart J, Metellus P, Fina F, Boucard C, Chinot O, Ouafik L and
Figarella-Branger D: Epidermal growth factor receptor in
glioblastomas: correlation between gene copy number and protein
expression. Hum Pathol. 41:815–823. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ilekis JV, Stark BC and Scoccia B:
Possible role of variant RNA transcripts in the regulation of
epidermal growth factor receptor expression in human placenta. Mol
Reprod Dev. 41:149–156. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Voelzke WR, Petty WJ and Lesser GJ:
Targeting the epidermal growth factor receptor in high-grade
astrocytomas. Curr Treat Options Oncol. 9:23–31. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Albitar L, Pickett G, Morgan M, Wilken JA,
Maihle NJ and Leslie KK: EGFR isoforms and gene regulation in human
endometrial cancer cells. Mol Cancer. 9:1662010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lafky JM, Wilken JA, Baron AT and Maihle
NJ: Clinical implications of the ErbB/epidermal growth factor (EGF)
receptor family and its ligands in ovarian cancer. Biochim Biophys
Acta. 1785:232–265. 2008.PubMed/NCBI
|
|
42
|
Shibata MA, Ambati J, Shibata E,
Albuquerque RJ, Morimoto J, Ito Y and Otsuki Y: The endogenous
soluble VEGF receptor-2 isoform suppresses lymph node metastasis in
a mouse immunocompetent mammary cancer model. BMC Med. 8:692010.
View Article : Google Scholar : PubMed/NCBI
|
